People · Operator
Named in public records as an officer, director or promoter · active 2019–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Stealth BioTherapeutics Corp | — | Biotechnology | Series B | $35.0M | $793.8M | 2019 |
Kevin McLaughlin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin McLaughlin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gerald Chan | 1 | 13 |
| Francis Chen | 1 | 3 |
| Lu Huang | 1 | 2 |
| Lou Lange | 1 | 1 |
| Edward Owens | 1 | 1 |
| Irene McCarthy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.